Biomarin Pharmaceutical Inc (BMRN)
Payables turnover
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 513,485 | 523,777 | 515,589 | 507,132 | 502,176 | 483,669 | 476,129 | 463,378 | 467,314 | 470,515 | 476,903 | 562,159 | 533,064 | 524,272 | 494,033 | 402,189 | 381,658 | 359,466 | 338,586 | 320,530 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
March 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $513,485K ÷ $—K
= —
To calculate Biomarin Pharmaceutical Inc's payables turnover, we need the values for accounts payable for consecutive quarters. Unfortunately, the provided table does not include the necessary data to compute the payables turnover ratio.
The payables turnover ratio is a liquidity metric that assesses how efficiently a company manages its accounts payable by comparing the amount of purchases made on credit to the average accounts payable outstanding during a period. A higher payables turnover ratio indicates that the company is paying its suppliers more quickly.
Without the specific accounts payable figures, it is not possible to analyze Biomarin Pharmaceutical Inc's payables turnover trend or make any conclusions regarding the company's payment efficiency over time.
Peer comparison
Mar 31, 2024